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Abstract
Magnetic resonance imaging is increasingly used for
abdominal evaluation and is more and more considered
as the optimal imaging technique for detection of mural
inﬂammation in patients with Crohn’s disease. Grading
the disease activity is important in daily clinical practice
to monitor the medical treatment and is assessed by
evaluating different magnetic resonance imaging fea-
tures. Unfortunately, only moderate interobserver
agreement is reported for most of the subjective features
and should be improved. A computer-assisted model for
automatic detection of abnormalities, ability to grade
disease severity, and thereby inﬂuence clinical disease
management based on magnetic resonance imaging is
missing. Recent techniques have focused on semi-auto-
mated methods for classiﬁcation and segmentation of the
bowel and also on objective measurement of bowel wall
enhancement using absolute T1-values or dynamic con-
trast-enhanced imaging. This article reviews the available
computerized techniques, as well as preferred develop-
ments.
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Abdominal magnetic resonance imaging (MRI) is widely
used for diagnosing and grading luminal Crohn’s disease
(CD). It typically involves a luminal (oral) and an
intravenous contrast medium in order to combine
transmural and extra-intestinal evaluation of disease
activity. Grading disease activity is important in daily
clinical practice to monitor the often costly and bur-
densome medical treatment and deﬁne treatment strate-
gies. In addition, pharmaceutical trials increasingly
employ MRI as outcome measure.
Conventionally, disease activity is assessed by evalu-
ating the presence of mural changes (e.g., wall enhance-
ment, bowel wall thickening, wall edema, and
stratiﬁcation), stenoses, length of the involved segments,
skip lesions and complications (e.g., ﬁstulas) [1–7]. In
fact, almost all articles on MRI in luminal CD use these
MRI features for assessment of disease activity [8, 9] and
these features are considered most important by inter-
national experts [10].
However, grading the disease activity based on these
MRI features has intrinsic limitations related to restric-
tions of the MRI technique. Also, it is a subjective
evaluation while varying weight is attributed to these
features. For instance, Jensen et al. [11] found only
moderate interobserver agreement (kappa = 0.48) in
detection of CD with MR enterography. Another recent
study by Ziech et al. [12] reported a weak to moderate
interobserver agreement for most of the subjective MRI
features. This is in accordance with other studies com-
paring interobserver variability of subjective MRI fea-
tures [13, 14]. A questionnaire among international
research groups showed that different weight is given to
certain features and different grading systems are used,
hampering comparison of study results [10]. For exam-
ple, some reviews [15, 16] presented absolute contrast
enhancement as a marker of disease activity, while others
dispute this [7, 17]. Based on the present methods of
grading, MRI has been shown to be accurate for severeCorrespondence to: Jeroen A.W. Tielbeek; email: j.a.w.tielbeek@
amc.uva.nl
ª The Author(s) 2011. This article is published with open access at Springerlink.com
Published online: 2 December 2011Abdominal
Imaging
Abdom Imaging (2012) 37:967–973
DOI: 10.1007/s00261-011-9822-x
disease (in 91% of cases accurate grading), but mediocre
for mild disease or remission (accurate grading in only
62% of cases) [18].
In a recent study Rimola et al. [19] used multivariate
analyses correlating radiological features to the Crohn’s
disease endoscopic index of severity (CDEIS). The
independent variables included in this regression analysis
were those with statistical significance (i.e., P < 0.05) in
a univariate test. As such, the regression analysis ren-
dered objectively determined weights that were attributed
to the independent variables in a Magnetic resonance
index of activity (MaRIA). This MaRIA score had a
high-diagnostic accuracy both in a derivation cohort and
an independent validation cohort for diagnosis of active
CD [20]. The study confirmed the radiologic changes that
should be evaluated to that end, which were wall thick-
ening, wall signal intensity, relative contrast enhance-
ment, the presence of edema, ulcers, enlarged lymph
nodes, and pseudopolyps.
Clearly, a system is preferred that renders a ﬁne
grading of the disease severity for accurate treatment
monitoring. Further, for surgical treatment the location
of the disease and the length of the involved segments are
important as well. At present the radiologist’s reading of
the length of involved segments is relatively cumbersome
and no data are available on the accuracy and the pre-
cision.
For an optimal evaluation of response monitoring,
MRI should be a robust, objective and reproducible
technique. Applying a (semi-)automated method might
improve the interobserver variation and allow a ﬁner
diagnosis scale as compared to the gross scale (remis-
sion—mild—severe) used by the radiologist. Therefore,
development of computer-assisted diagnosis tools for
quantitative image-based analysis of CD is pivotal. This
article aims at reviewing the semi-automated techniques
that are currently available for assessment of CD severity.
Semi-automated methods in Crohn’s
disease
The literature on semi-automated methods in CD is very
sparse. Much work that has been done on (semi-)auto-
mated methods related to imaging of the gastrointestinal
tract concerns CT colonography. Speciﬁcally, over the
past years many (semi-)automated techniques for CT
colonography were developed such as sophisticated
techniques for visualization of the bowel surface [21],
electronic bowel cleansing [22], and computer aided
detection [23] in CT colonography. These techniques
proved helpful and have led to the use of these tech-
niques in daily practice.
One might expect that such methods can be used in
MRI of Crohn’s disease as well. However, in contrast to
the values in CT images, which represent well repro-
ducible CT numbers, values in MR images depend on a
large number of variables and have no absolute meaning.
Speciﬁcally, MRI images are inﬂuenced by signal ﬂuc-
tuations that emanate both from global (bias ﬁeld) as
well as local effects (heterogeneities in tissue). The
resulting variation in signal value precludes simple ap-
proaches (e.g., thresholding) for MRI data. Presumably,
the complexity of processing MR data has resulted in
a limited number of practically used and studied
techniques.
One study reports on automated methods that take
into account multiple imaging features to identify small
bowel loops (segmentation) and to quantify aspects of
disease severity (feature measurement) [8, 24]. A 2D
steady-state free precession (FIESTA) scan was used in
combination with a fat suppressed scan to correctly
segment the bowel. Registration of the scans was needed,
because of patient motion and temporal movement of the
bowel. The FIESTA scans served as input for a Gaussian
classifier which tentatively divided the dataset into
different components: fat, muscle/background and
enhancing bowel. The remaining bowel regions were
finally segmented on the fat suppressed scan. The oper-
ator could then select the objects of interest and label
them as enhancing bowel. In the end, this might help to
objectively assess inflammation, and determine its mul-
tifocality, severity, length, and radial involvement.
Unfortunately, complete automation seemed to be
not feasible due to the variability in the intensity values
and signiﬁcant artefacts that emanated from the imaging
process. The proposed image processing methods were
designed to facilitate the evaluation process and reduce
the effort required by the radiologist to a few minutes.
The registration, classiﬁcation, and segmentation might
be further automated by the application of prior
knowledge and heuristic rules [24]. Therefore, additional
research is required.
Another development concerns objective measure-
ments of enhancement. Pathological increase in bowel
wall T1-signal intensity (enhancement) after intravenous
(IV) administration of Gadolinium is an important
characteristic of active CD (see above) [2, 10]. The in-
crease of the longitudinal relaxation rate (1/T1) is di-
rectly proportional to the tissue concentration of the
contrast medium [26]. Therefore, calculation of the
absolute T1-values in tissue before and after IV injection
of Gadolinium would provide objective measurements of
the Gadolinium-uptake. Inter- and intraobserver vari-
ability of manual measurement of the bowel wall
enhancement is reported to be poor, but improving after
choosing fixed regions-of-interest (ROI) [15, 27]. As
such, bowel wall enhancement may be assessed in a more
objective manner.
Alternatively, methods have been evaluated to
objectively score disease activity in patients with CD
using features of the uptake curves from dynamic
contrast-enhanced (DCE-) MRI [1]. The slope of
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enhancement, a semi-quantitative parameter, has corre-
lated negatively with microvessel density and positively
with disease chronicity suggesting that chronic low per-
fusion may stimulate new vessel formation [28]. Semi-
quantitative parameters such as curve shape have also
been found to correlate with disease score in perianal CD
[29]. All such quantitative parameters are in themselves
reviewer-independent.
Fig. 1. Forty-two-year-old female patient with Crohn’s dis-
ease who previously underwent an ileocecal resection. A
Coronal balanced steady-state free precession (true-FISP)
image with fat saturation, B coronal T1-weighted volume
interpolated breath hold imaging (VIBE) post contrast image
with fat saturation, C transverse Half-Fourier single shot
RARE (HASTE) image, and D transverse T1-weighted VIBE
post contrast image with fat saturation shows bowel wall
thickening and post contrast mucosal wall enhancement. On
the HASTE sequence high signal intensity of the bowel wall
due to oedema is visible (arrow), it could also be related to fat
in the wall but based on the other sequences this could be
excluded (use of (additional) fat saturation HASTE sequence
is preferable; see Fig. 2E). The mucosal wall enhancement
and the high signal intensity on T2 (HASTE) are features
indicating acute disease activity. The length of the affected
segment is approximately 40 cm.
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Discussion
There is a clear demand for semi-automated evaluation
of MR images in CD. Currently, a computer-assisted
diagnosis tool for automatic detection of abnormalities,
ability to grade disease severity, and thereby inﬂuence
clinical disease management based on MRI is missing.
Development of such a system is a complex task, par-
ticularly due to the signal ﬂuctuation inherent to MRI.
Moreover, the limited thickness of the bowel wall and the
presence of peristalsis further complicates the develop-
ment of new techniques. A combination of (semi-)auto-
mated segmentation and different registration techniques
to identify, respectively, align regions of interest in MRI
images would be extremely useful. This should facilitate
the measurement of descriptive properties of CD activity
in the images and the application of pattern recognition
techniques to detect and rate abnormalities. In turn, the
latter would support the establishment of a combined,
objective, and quantitative disease severity index.
It may be anticipated that such tools requires several
technical developments.
An important step in the development of a computer-
assisted model might be the (semi-)automated identiﬁ-
cation of the bowel surface. Initially, a radiologist could
manually select a region in an intestinal segment where
CD activity is expected. Subsequently, the model would
locally identify the bowel wall, from which the wall
thickness and enhancement could be deduced. In addi-
tion, the model might give the length of the affected part
of the segment. The model would assist the radiologist in
this way by objectively quantifying features of the af-
fected bowel segment, which in itself already could be
very useful in the follow-up of patients.
Fully automated object detection (detection of dis-
eased regions without user interaction) is considered a
very difﬁcult task in the context of MR imaging, which
may not be achieved shortly. Clearly, such a system
would be favourable in the future, though.
Registration of the different MRI images to have
spatially corresponding data might be a crucial step in
the development of a computer-assisted model [24]. This
would facilitate a combined assessment of multiple MRI
features (bowel wall thickness, signal intensity on T2-
weighted images, enhancement after intravenous con-
trast and stratification) from different sequences. As
such, it may provide the radiologist a better overview of
the location and characteristics of the abnormalities in
the GI tract. For example, to determine whether an
intestinal segment is fibrotic or not, a radiologist has to
evaluate the signal intensity and stratification of the
bowel wall on a post contrast T1-weighted sequence and
a T2-weighted sequence (Figs. 1, 2).
Based on the aforementioned features (e.g., bowel
wall thickness, signal intensity on fat sat T2, layered
enhancement), a sophisticated pattern recognition
technique might automatically compute the probability
that the segment is affected by CD, and even determine if
it is ﬁbrosed and/or inﬂamed. Subsequently, the radiol-
ogist could be informed about the characteristics of the
segment at a glance.
Eventually, the tool could even indicate the grade of
inﬂammation of the segment by means of visualization
techniques thereby improving the perception and accel-
erating the recognition time [30].
A further highly needed technical development will be
to combine MR, laboratory (e.g., C-reactive protein) and
clinical data (e.g., the Harvey Bradshaw index [31] or
Crohn’s Disease activity index [32]) for a more reliable
and precise diagnostic performance. The combination of
quantitative imaging and clinical biomarkers of disease
will activity draw on the strengths of both methodologies
and it is anticipated that it will add to the robustness of
any predictive model.
Moreover, a visualization software toolbox could
enable interactive visualization of the bowel and the
bowel wall characteristics. It will feature techniques for
concurrent visualization of the multiscale clinical patient
data as well as the properties measured by image analysis
and classiﬁcation.
Finally, it is expected that patient education will be
supported by developed visualization techniques. Patient
education is becoming an increasingly important aspect of
medical care. Illustrations can be a valuable aid in
explaining diagnoses and treatments [33]. Recent progress
[34] in the area of illustrative visualization seeks to repro-
duce the expressiveness and comprehensibility of tradi-
tional illustrations using advancedvisualization techniques.
Perceptually effective visualization techniques as well
as methods to evaluate their effectiveness will support
this development [30]. Such an approach makes it feasi-
ble to generate patient-specific depictions of particular
pathologies which are easy to understand for laymen.
Similar techniques may also be used to aid medical
education and communication [35].
Fig. 2. The same Crohn’s disease patient as in Fig. 1;
nine months later after treatment with adalimumab (HUMIRA,
Abbott). A Coronal true-FISP image, B coronal T1-weighted
VIBE post contrast image, C transverse HASTE image, D
transverse T1-weighted VIBE post contrast image, E axial
HASTE image with fat saturation and F an axial true-FISP
sequence shows wall thickening and still increased enhance-
ment. Edema has decreased as compared to Fig. 1, indicating
less active disease. Prominent engorged vasa recta in the
mesentery (comb sign) are also identified (asterisk). The length
of the affected segment remains approximately 40 cm. Map-
ping different sequences by ICT tools would give the radiologist
a better overview of the same segment, and a better insight in
differentiating between fibrosis and inflammation. Further,
objective measurement of the length and/or wall enhancement
would help the radiologist and gastroenterologist in therapy
monitoring.
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Conclusion
(Semi-)automated assessment of Crohn’s disease is not
ﬁction anymore as already limited tools are available.
However, substantial steps have to be made to come to
robust (semi-)automated assessment tools. It would be a
ground-breaking development if the radiologist could be
assisted by automatic detection and quantiﬁcation of
abnormalities at MRI of the gastrointestinal tract and
have an objective assessment of disease severity.
To that end ICT tools should be created that extract
regions of interest (semi-)automatically from MRI data,
analyze the small bowel by use of mural features, use a
classiﬁer to predict the presence of active Crohn‘s disease
and the ability to grade disease severity in the near future.
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